Medicines
- Augtyro repotrectinib · No generic yet Advanced solid tumors with an NTRK gene fusion
- Enhertu fam-trastuzumab deruxtecan-nxki · No generic yet HER2-positive solid tumors
- Jemperli dostarlimab · No generic yet Advanced solid tumors with dMMR (mismatch repair deficient)
- Keytruda Qlex pembrolizumab and berahyaluronidase alfa-pmph · No generic yet Solid tumors with MSI-H, dMMR or TMB-H test results
- Mekinist trametinib · No generic yet Other solid tumors with a BRAF mutation
- Retevmo selpercatinib · No generic yet Other solid tumors with a RET gene fusion
- Rozlytrek entrectinib · No generic yet Solid tumors with an NTRK gene fusion
- Tafinlar dabrafenib · No generic yet Solid tumors with a BRAF gene change
- Vitrakvi larotrectinib · No generic yet Solid tumors with an NTRK gene fusion